Curanex Pharmaceuticals Inc
CURX
$0.62
$0.011.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.25% | 33.58% | -39.05% | -34.73% | 403.09% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | 425.00% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 21.48% | 33.41% | 12.47% | 11.98% | -- |
| Total Current Assets | 2.18% | 34.41% | -9.36% | -14.26% | -- |
|
|
|||||
| Total Current Assets | 2.18% | 34.41% | -9.36% | -14.26% | -- |
| Net Property, Plant & Equipment | -16.61% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 51.21% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.04% | 51.94% | -19.84% | -9.74% | -- |
|
|
|||||
| Total Accounts Payable | -99.76% | 2,422.00% | -- | -- | -- |
| Total Accrued Expenses | 28.21% | -59.38% | 71.43% | 833.33% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.78% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -60.59% | 1,219.18% | 160.71% | 833.33% | -- |
|
|
|||||
| Total Current Liabilities | -60.59% | 1,219.18% | 160.71% | 833.33% | -- |
| Long-Term Debt | 100.00% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -79.72% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.36% | 2,784.93% | 160.71% | 833.33% | -- |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 2.80% | -- |
| Retained Earnings | -7.95% | -22.11% | -28.25% | -25.95% | -- |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Common Equity | -16.52% | -27.34% | -21.41% | -10.45% | 1,089.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -- |
|
|
|||||
| Total Common Equity | -16.52% | -27.34% | -21.41% | -10.45% | 1,089.85% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.51% | -27.33% | -21.41% | -10.44% | 1,090.02% |
|
|
|||||